NO912561L - Fremgangsmaate for fremstilling av ws7622a mono- eller disulfat. - Google Patents

Fremgangsmaate for fremstilling av ws7622a mono- eller disulfat.

Info

Publication number
NO912561L
NO912561L NO91912561A NO912561A NO912561L NO 912561 L NO912561 L NO 912561L NO 91912561 A NO91912561 A NO 91912561A NO 912561 A NO912561 A NO 912561A NO 912561 L NO912561 L NO 912561L
Authority
NO
Norway
Prior art keywords
disulphate
preparing
procedure
ws7622a
mono
Prior art date
Application number
NO91912561A
Other languages
English (en)
Other versions
NO912561D0 (no
NO301643B1 (no
Inventor
Shigehiro Takase
Hiroshi Hatanaka
Masami Ezaki
Eisaku Tsujii
Masanori Okamoto
Nobuharu Shigematsu
Masakuni Okuhara
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO912561D0 publication Critical patent/NO912561D0/no
Publication of NO912561L publication Critical patent/NO912561L/no
Publication of NO301643B1 publication Critical patent/NO301643B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/04—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
NO912561A 1990-06-29 1991-06-28 Analogifremgangsmåte for fremstilling av et terapeutisk aktivt WS7622A disulfat eller salter derav NO301643B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909014546A GB9014546D0 (en) 1990-06-29 1990-06-29 Ws7622a mono-or di-sulfate,process for preparation thereof and use thereof

Publications (3)

Publication Number Publication Date
NO912561D0 NO912561D0 (no) 1991-06-28
NO912561L true NO912561L (no) 1991-12-30
NO301643B1 NO301643B1 (no) 1997-11-24

Family

ID=10678456

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912561A NO301643B1 (no) 1990-06-29 1991-06-28 Analogifremgangsmåte for fremstilling av et terapeutisk aktivt WS7622A disulfat eller salter derav

Country Status (22)

Country Link
US (2) US5292510A (no)
EP (1) EP0465895B1 (no)
JP (1) JP2663763B2 (no)
KR (1) KR100198693B1 (no)
CN (1) CN1073115C (no)
AT (1) ATE138074T1 (no)
AU (1) AU640241B2 (no)
CA (1) CA2045761C (no)
DE (1) DE69119488T2 (no)
DK (1) DK0465895T3 (no)
ES (1) ES2087178T3 (no)
FI (1) FI106554B (no)
GB (1) GB9014546D0 (no)
GR (1) GR3020184T3 (no)
HU (1) HU213398B (no)
IE (1) IE75702B1 (no)
IL (1) IL98394A (no)
NO (1) NO301643B1 (no)
PH (1) PH31239A (no)
PT (1) PT98134B (no)
RU (1) RU2087482C1 (no)
ZA (1) ZA914349B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69223455T2 (de) * 1991-06-18 1998-04-02 Fujisawa Pharmaceutical Co WS7622A enthaltende prophylaktische/therapeutische Zusammensetzung zur Vorbeugung und Behandlung von verstreuter, intravaskulärer Koagulation, chronischer, infektiöser Atemwegskrankheiten oder chronischer Bronchitis
US5384119A (en) * 1993-08-12 1995-01-24 Merrell Dow Pharmaceuticals Inc. Method of preventing neutrophil mediated connective tissue damage
JP2002161051A (ja) * 1996-12-24 2002-06-04 Fujisawa Pharmaceut Co Ltd 脳虚血性疾患等の治療剤
WO1999043352A1 (en) * 1998-02-24 1999-09-02 Fujisawa Pharmaceutical Co., Ltd. Preventives/remedies for skin aging
CN109406709B (zh) * 2018-12-27 2020-11-10 福建省中医药研究院(福建省青草药开发服务中心） 一种太子参药材中氨基酸类成分的薄层鉴别方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27266A (en) * 1989-03-14 1993-05-04 Fujisawa Pharmaceutical Co WS7622, A,B,C and D substances and pharmaceutical composition containing same

Also Published As

Publication number Publication date
AU7939491A (en) 1992-01-09
CA2045761A1 (en) 1991-12-30
KR920000920A (ko) 1992-01-29
HU213398B (en) 1997-06-30
IL98394A (en) 1995-03-30
ES2087178T3 (es) 1996-07-16
AU640241B2 (en) 1993-08-19
PT98134B (pt) 1998-12-31
FI912914L (fi) 1991-12-30
IL98394A0 (en) 1992-07-15
IE912047A1 (en) 1992-01-01
DE69119488T2 (de) 1996-10-02
ZA914349B (en) 1992-03-25
DE69119488D1 (de) 1996-06-20
RU2087482C1 (ru) 1997-08-20
GR3020184T3 (en) 1996-09-30
NO912561D0 (no) 1991-06-28
FI106554B (fi) 2001-02-28
NO301643B1 (no) 1997-11-24
CN1073115C (zh) 2001-10-17
PT98134A (pt) 1992-06-30
EP0465895B1 (en) 1996-05-15
JP2663763B2 (ja) 1997-10-15
US5292510A (en) 1994-03-08
HUT58351A (en) 1992-02-28
EP0465895A1 (en) 1992-01-15
FI912914A0 (fi) 1991-06-17
CN1057655A (zh) 1992-01-08
JPH04279600A (ja) 1992-10-05
ATE138074T1 (de) 1996-06-15
IE75702B1 (en) 1997-09-10
PH31239A (en) 1998-06-18
CA2045761C (en) 1999-09-21
KR100198693B1 (ko) 1999-06-15
GB9014546D0 (en) 1990-08-22
DK0465895T3 (da) 1996-06-03
US5364624A (en) 1994-11-15
HU912198D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
HUT54144A (en) Process for producing 3-desmethylmevalonic acid derivatives and pharmaceutical compositions comprising same as active ingredient
NO942953L (no) 11-benzaldoksimestradienderivater, fremgangsmåte for deres fremstilling smat legemddel inneholdende slike
DE69317877D1 (en) 4''-deoxyerythromycinderivate
AU6750881A (en) Cephalosporin derivatives
HUT49614A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising these compounds
FI891581A0 (fi) Peptidderivat.
AU1891683A (en) Substituted 1-phenyl-isoquinoline anti-arrythmic agents
NO912561D0 (no) Fremgangsmaate for fremstilling av ws7622a mono- eller disulfat.
HU901427D0 (en) Process for the preparation of ws7622 a, b, c and d
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
HUT49886A (en) Process for producing new beta-lactam antibiotics and pharmaceutical compositions comprising same
PT81118A (en) Process for preparing novel antibiotics and pharmaceutical compositions therefrom
ZA828237B (en) A vasodilator compound,process for the preparation thereof and pharmaceutical compositions therefrom
IE901180L (en) Polar cephalosporin derivatives and a process for the¹preparation thereof
HUT53654A (en) Process for producing cefemcarboxylic acid compounds and pharmaceutical compositions comprising such compounds

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees